a developer of non-invasive blood tests for the early detection of solid tumor based cancers
Industry Biotechnology
A.I.dvisor tells us that ANIX and GERN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANIX and GERN's prices will move in lockstep.
Ticker / NAME | Correlation To ANIX | 1D Price Change % | ||
---|---|---|---|---|
ANIX | 100% | -7.66% | ||
GERN - ANIX | 32% Poorly correlated | -4.07% | ||
SER - ANIX | 27% Poorly correlated | +27.97% | ||
RPTX - ANIX | 25% Poorly correlated | -13.70% | ||
ALLO - ANIX | 25% Poorly correlated | -7.97% | ||
SAGE - ANIX | 24% Poorly correlated | -4.55% | ||
More |